Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Rituximab
Rituximab
Routinely available
Local application
27/03/2024
Indication
For use in moderate to severe pemphigus vulgaris.
Therapeutic Area
Skin
Status Description
Routinely available in line with local or regional guidance
Formulation
Solution for infusion